Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1474418Generated: October 29, 2026

5-(Oxiran-2-yl)-2,1,3-benzoxadiazole → 5-[(1R)-2-{4-[(2R)-2-(2,1,3-benzoxadiazol-5-yl)-2-hydroxyethyl]piperazin-1-yl}-1-hydroxyethyl]-4-methyl-2-benzofuran-1(3H)-one

https://huagongshe.com/reaction/1474418

Reaction equation

Participants

RoleNameHCIDCharge
Reactant5-(Oxiran-2-yl)-2,1,3-benzoxadiazoleHCID 59568661—
Reactant5-[(1R)-1-hydroxy-2-piperazin-1-ylethyl]-4-methyl-2-benzofuran-1(3H)-oneHCID 59568728—
Product5-[(1R)-2-{4-[(2R)-2-(2,1,3-benzoxadiazol-5-yl)-2-hydroxyethyl]piperazin-1-yl}-1-hydroxyethyl]-4-methyl-2-benzofuran-1(3H)-oneHCID 59568725—

Reaction Steps

The title compounds were prepared as described for the synthesis of EXAMPLES 57-58 starting from 5-[(1R)-1-hydroxy-2-(piperazin-1-yl)ethyl]-4-methyl-2-benzofuran-1(3H)-one and 5-(oxiran-2-yl)-2,1,3-benzoxadiazole. The resulting two diastereomers were resolved by prep SFC on Chiralcel OJ 30×200 mm column eluting with 70 mL/min of 30% methanol (0.2% DEA)/CO2 at 35° C. with pressure of 100 bar.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09018211B2
Source datasetuspto-grants-2015_04
ORD IDord-8a917d9303c84fc1aecc5047a26d5927
Source noteuspto-grants-2015_04